BTG International
BTG focuses on developing and commercializing of pharma products for cancer, vascular and emphysema diseases.
Business Model:
Revenue: $870.5M
Employees: 1,001-5,000
Detailed BTG International Information
BTG International was acquired by
Boston Scientific.
The acquisition happend on 2018-11-20.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 5 Fleet Place
City: London
State: england
Zip: EC4M 7RD
Country: GB
Financial Info
Stage:
series unknown
Raised Last:
$4M
Raised Total:$8M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
BTG focuses on developing and commercializing of pharma products for cancer, vascular and emphysema diseases.
Contact Phone:
+18442930007
Contact Email:
BTG International went public on the London Stock Exchange
Listed Exchange:
London Stock Exchange
Ticker Symbol:
BTG
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2004 | Avera Pharmaceutical | Series C | 0 |
| 9/2003 | Xention | Venture Round | 6.4M |
| 5/2006 | QuNano | Series A | 6.1M |
| 7/2019 | New Radiomedicine Technology | Series B | 16.9M |
| 2/2004 | Protez Pharmaceuticals | Series A | - |
| 2/2003 | Senexis | Seed Round | 2.3M |
| 4/2004 | Ignios | Series A | 0 |
| 11/2018 | Veran Medical Technologies | Venture Round | 20M |
| 7/2019 | New Radiomedicine Technology | Series B | 0 |
| 11/2018 | Veran Medical Technologies | Venture Round | 0 |
| 5/2006 | QuNano | Series A | 0 |
| 8/2004 | Avera Pharmaceutical | Series C | 0 |
| 4/2004 | Ignios | Series A | 0 |
| 2/2004 | Protez Pharmaceuticals | Series A | - |
| 9/2003 | Xention | Venture Round | 0 |
| 2/2003 | Senexis | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2015 | Unattributed | $4.1M | 2/2016 | Venture Round | $4.1M | 1/2015 | Convertible Note | $4M | 6/2015 | Convertible Note | $3.9M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 9/2018 | Novate Medical | |
| 10/2017 | Roxwood Medical | |
| 5/2016 | Galil Medical | |
| 12/2014 | PneumRx | |
| 5/2013 | EKOS Corporation | |
| 11/2010 | Biocompatibles International | |
| 9/2008 | Protherics | |
| 3/2005 | CellMed AG |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
